WuXi Biologics (Cayman) I... (WXIBF)
OTC: WXIBF
· Real-Time Price · USD
4.70
0.00 (0.00%)
At close: Sep 05, 2025, 9:34 AM
4.70
0.00%
Pre-market: Sep 05, 2025, 09:34 AM EDT
WuXi Biologics (Cayman) Revenue
WuXi Biologics (Cayman) reported an annual revenue of $18.68B, reflecting a 9.63% growth. For the quarter ending December 31, 2024, WuXi Biologics (Cayman) generated $10.1B in revenue.
Revenue (ttm)
18.68B
Revenue Growth
9.63%
Price / Sales Ratio
3.46
Revenue / Employee
1.49M
Employees
12,575
Market Cap
19.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 18.68B | +9.63% |
| Dec 31, 2023 | 17.03B | +11.56% |
| Dec 31, 2022 | 15.27B | +48.38% |
| Dec 31, 2021 | 10.29B | +83.35% |
| Dec 31, 2020 | 5.61B | +40.88% |
| Dec 31, 2019 | 3.98B | +57.18% |
| Dec 31, 2018 | 2.53B | +56.56% |
| Dec 31, 2017 | 1.62B | +63.68% |
| Dec 31, 2016 | 989.03M | +77.55% |
| Dec 31, 2015 | 557.04M | +67.86% |
| Dec 31, 2014 | 331.85M | n/a |